# GTCR to acquire Surmodics for $627 million

Surmodics entered into a definitive agreement to be acquired by private equity firm GTCR for $43.00 per share in cash, representing an equity value of approximately $627 million.

- Type: Acquisition
- Announced: 2024-05-29
- Where: United States
- Value: $627.0M
- Status: announced
- Products: medical devices, in vitro diagnostic technologies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [GTCR](https://endata.com/companies/8467.md) (acquirer)
- [Surmodics](https://endata.com/companies/30343.md) (target)

## Sources

- [surmodics.gcs-web.com](https://surmodics.gcs-web.com/news-releases/news-release-details/surmodics-enters-definitive-agreement-be-acquired-gtcr-4300), 2024-05-29: "Surmodics, Inc. today announced that it has entered into a definitive agreement to be acquired by GTCR."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.